-----Original Message----- From: INSTRAW [mailto:[EMAIL PROTECTED]] Sent: Monday, April 01, 2002 7:52 AM To: [EMAIL PROTECTED] Subject: FW: [gender-aids] Request for articles: Treatment Access and Gender -----Original Message----- From: [EMAIL PROTECTED] [mailto:[EMAIL PROTECTED]]On Behalf Of [EMAIL PROTECTED] Sent: Friday, March 29, 2002 3:44 AM To: Gender-AIDS Subject: [gender-aids] Request for articles: Treatment Access and Gender How does gender impact on access to treatment? Hella von Unger, Germany ************************ Hi everyone, A friend asked me to write an article for the newspaper of the national body of leftist student organizations (FZS) in Germany - a good opportunity to introduce access to treatment issues and the MNC campaign to student politics in Germany, I think. The issue will have a feminist focus, so I thought I might write a piece on access to treatment viewed through a gender lens. Does anyone know of any articles that address the issue of how access/no access to treatment affects men and women differently in high prevalence countries? I'm aware of a huge body of research on the greater vulnerability of women to HIV (in terms of transmission and prevention), but the only studies on gender and health disparities in the context of HIV/AIDS treatment and care that I have seen were conducted in industrialized countries. Yet I wonder whether the same thing (women being treated as second class citizens and patients) is happening in other countries, too? I am thinking of MTCT programs in some African countries, for example, where there is nevirapine to protect foetuses from becoming infected, but there are hardly any treatment options for mothers with HIV/AIDS. Or take our MNC campaign - we're asking for treatment at the workplace - who is being employed? I bet more men than women. (Which is why we're asking for treatment for employees AND their families and sex partners, no?!) I guess my point is that there is always a danger of reinforcing existing social inequalities, be it inequalities along the lines of gender, employment, race, you name it. If anyone wants to share thoughts on how gender (in combination with race, class etc) impacts on access to treatment in high prevalence countries - please let me know! Suggestions for useful literature would also be most appreciated! Thanks a lot, Hella Hella von Unger (212) 316 2659 [EMAIL PROTECTED] *---* A posting from GENDER-AIDS ([EMAIL PROTECTED]) To submit a posting, send to: [EMAIL PROTECTED] For anonymous postings, add the word "anon" to the subject line To join, send a blank message to: [EMAIL PROTECTED] To leave send a blank email to: [EMAIL PROTECTED] You are currently subscribed to gender-aids as: [EMAIL PROTECTED] Archives before 23 December 2001: www.hivnet.ch:8000/gender-aids Archives after 23 December 2001: archives.healthdev.net/gender-aids *********** The forum is moderated by the Health & Development Networks (HDN) Moderation Team - http://www.hdnet.org - on behalf of the Fondation du Present (FdP) with technical support from HST. The views expressed in this forum do not necessarily reflect those of HDN, FdP and HST. Reproduction welcomed, provided source and forum email address is quoted as follows: Copyright GENDER-AIDS 2002 Email: [EMAIL PROTECTED] =========================================================================== This is GainsNet, the mailing list of the UN-INSTRAW-GAINS Network Members. To reply to the GainsNet group, click on "reply all" To reply to an individual, click on "reply" To unsubscribe from GainsNet, send an email to [EMAIL PROTECTED] with the word "unsubscribe" in the subject line
